Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Advanced Lung Cancer: A Year in Review
EP. 1: Work-Up and Management of Nondriver Metastatic Lung Cancer
April 13th 2020
EP. 2: Therapy Approach for PD-L1 Over 50% Lung Cancer
April 13th 2020
EP. 3: Progression on Immunotherapy: Treatment Approach
April 13th 2020
EP. 4: PD-L1 Less Than 49%: Available Treatments
April 13th 2020
EP. 5: Immunotherapy and Brain Metastatic Lung Cancer
April 13th 2020
EP. 6: How Long to Continue Immunotherapy
April 13th 2020
EP. 7: The IMpower150 Regimen
April 13th 2020
EP. 8: When to Use the CheckMate-227 Regimen
April 13th 2020
EP. 9: Lung Cancer Molecular Testing Protocol
April 13th 2020
EP. 10: Upfront Targeted Treatment Approach
April 13th 2020
EP. 11: Oligometastatic and Small Cell Transformation Management
April 13th 2020
EP. 12: When to Re-Treat with Osimertinib
April 13th 2020
EP. 13: ALK-Rearranged & MET Exon 14 NSCLC Treatment Options
April 13th 2020
EP. 14: Brain Metastatic NSCLC: Targeted Therapy Approach
April 13th 2020
EP. 15: Unresectable Stage III Lung Cancer Management
April 13th 2020
EP. 16: Stage III NSCLC: When to Start Durvalumab
April 13th 2020
EP. 17: Stage III NSCLC Progression Treatment Strategy
April 13th 2020
EP. 18: Small-Cell Lung Cancer: The IMpower133 and CASPIAN trials
April 13th 2020
EP. 19: Limited-Stage SCLC: Is Immunotherapy an Option?
April 13th 2020
EP. 20: The Future of Lung Cancer Management
April 13th 2020